Dr. Michael Anthony Ciliberto, MD
- Medicare patients, 2024
- 12
- Part D claims, 2024
- 459
- Publications
- 24
- Clinical trials
- 3
- MIPS score, 2024
- 80
- Practice address
- 200 Hawkins Drive, Iowa City, IA 52242
- Practice phone
- Call (319) 356-1616
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Ciliberto's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Michael Anthony Ciliberto is an epilepsy physician in Iowa City, Iowa
Dr. Ciliberto practices at University of Iowa Health Care Medical Center in Iowa City, Iowa, part of The University of Iowa.
Dr. Ciliberto's NPI, 1043418809, was assigned on July 3, 2007. Dr. Ciliberto graduated from Washington University School of Medicine in 2005. Dr. Ciliberto holds Iowa license MD-41060.
- NPI
- 1043418809NPI Registry (opens in a new tab)
- Medicare PAC ID
- 4183801491
- NPI enumeration date
- July 3, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (319) 356-1616
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 47
- Medical school graduation
- 2005
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Michael Anthony Ciliberto practices at University of Iowa Health Care Medical Center in Iowa City, Iowa
Dr. Ciliberto's primary practice is University of Iowa Health Care Medical Center, at 200 Hawkins Drive, Iowa City, IA 52242 in Johnson County. The practice phone is (319) 356-1616.
- University of Iowa Health Care Medical Center200 Hawkins Drive, Iowa City, IA 52242 · Johnson CountyPhone(319) 356-1616
Source: Dmand AI Affiliation Data
Dr. Michael Anthony Ciliberto is affiliated with 1 site of care and 1 medical group
Dr. Ciliberto's primary practice is University of Iowa Health Care Medical Center in Iowa City, Iowa, part of The University of Iowa. The medical group on file is Scanlan Center for School Mental Health Clinic.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Michael Anthony Ciliberto's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ciliberto practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| University of Iowa Health Care Medical Center | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across The University of Iowa and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Michael Anthony Ciliberto is one of 11 epilepsy physicians in Iowa
Epilepsy is Dr. Ciliberto's primary specialty in the NPI Registry, under taxonomy code 2084E0001X. Dmand AI has Dr. Ciliberto's licenses on file in 2 states: Iowa and Missouri.
Specialties and state licenses
- Epilepsy, IowaPrimary
- Neurology with special qualifications in child neurology, Missouri
Epilepsy physicians near Dr. Ciliberto
Counts of epilepsy physicians with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Michael Anthony Ciliberto treated 12 Medicare patients in 2024, average age 30
CMS counts 12 Medicare patients who saw Dr. Ciliberto in 2024. The largest group is under 65, with 12 patients. Their average risk score is 0.98, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. Ciliberto's median patient age at 16, with 41% women.
Dr. Ciliberto's Medicare patients by age, 2024
Dr. Ciliberto's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 16
Patient panel by sex, all payers
- Women41%
- Men58%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Michael Anthony Ciliberto wrote 459 Medicare Part D claims in 2024
In 2024, Dr. Ciliberto wrote 459 Medicare Part D claims for 18 patients. 78% of them were for generic drugs. CMS names the drug for 412 of them, across 17 drugs with 11 or more claims each, at $147,632 in total drug cost. In 2023, CMS named 370 claims across 17 drugs.
Dr. Ciliberto's Part D claims by kind of drug, 2024
- Generic357 claims78%
- Brand-name89 claims19%
- Other13 claims3%
Dr. Ciliberto's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 3702024: 41211%
Drugs named by CMS: 17 in 2024, 17 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Michael Anthony Ciliberto scored 80 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Ciliberto for performance year 2024, reported as part of a group. Dr. Ciliberto accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Ciliberto's MIPS scores, performance year 2024
- 80of 100Final score
- 75.7of 100Quality
- 78of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Michael Anthony Ciliberto has 24 publications on record
Dmand AI links 24 papers to Dr. Ciliberto, published from 2011 to 2025. 2023 was the busiest year, with 4. The most frequent topics are Epilepsy, Seizures and Drug Resistant Epilepsy. Dr. Ciliberto has published most often in Epilepsia. Dr. Ciliberto's most frequent co-authors are Lily C. Wong-Kisiel, MD, Rani Kaur Singh, MD and Brian J. Dlouhy, MD.
Dr. Ciliberto's papers by year, 2012 to 2025
Topics Dr. Ciliberto writes about most
- Epilepsy
- Seizures
- Drug Resistant Epilepsy
- Electroencephalography
- Magnetic Resonance Imaging
- Palliative Care
- Amygdala
- Anticonvulsants
Dr. Ciliberto's most frequent co-authors
- Lily C. Wong-Kisiel, MD8 shared papers
- Rani Kaur Singh, MD6 shared papers
- Brian J. Dlouhy, MD5 shared papers
Recent publications by Dr. Ciliberto
See who Dr. Ciliberto researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Ciliberto works with, so you can find a warm path to the right epilepsy physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Michael Anthony Ciliberto has worked on 3 clinical trials
Dmand AI links Dr. Ciliberto to 3 clinical trials, 3 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Epilepsies, Myoclonic, Lennox Gastaut Syndrome and Epilepsy, Generalized. Takeda sponsors the most, 3.
Conditions in Dr. Ciliberto's trials
- Epilepsies, Myoclonic
- Lennox Gastaut Syndrome
- Epilepsy, Generalized
- Epileptic Syndromes
Investigators on the most trials with Dr. Ciliberto
- Ronald G. Davis, MD3 shared trials
- Orrin Devinsky, MD3 shared trials
- Julio Robert Flamini, MD3 shared trials
Recent clinical trials with Dr. Ciliberto
A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut Syndrome (opens in a new tab)
A Study of Soticlestat as an Add-on Therapy in Children, Teenagers, and Adults With Lennox-Gastaut Syndrome (opens in a new tab)
A Study of Soticlestat as an Add-on Therapy in Children and Young Adults With Dravet Syndrome (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Michael Anthony Ciliberto received $2,798 in industry payments from 2016 to 2024
CMS Open Payments shows 7 general payments to Dr. Ciliberto from 5 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 50% of the total. Zogenix Inc. paid the most, $1,400.
General payments to Dr. Ciliberto by program year, 2016 to 2024
General payments to Dr. Ciliberto by kind, 2016 to 2024
- Consulting fees$1,40050%
- Travel and lodging$1,31147%
- Food and beverage$863%
- Education$10%
Companies that paid Dr. Ciliberto the most, 2016 to 2024
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Michael Anthony Ciliberto graduated from Washington University School of Medicine
Dr. Ciliberto graduated from Washington University School of Medicine in 2005.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Michael Anthony Ciliberto's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Michael Anthony Ciliberto
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Michael Anthony Ciliberto's NPI number?
Dr. Michael Anthony Ciliberto's NPI number is 1043418809. It was assigned on July 3, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Michael Anthony Ciliberto?
Dr. Michael Anthony Ciliberto is an epilepsy physician in Iowa City, Iowa. The primary specialty in the NPI Registry is Epilepsy Physician (taxonomy code 2084E0001X).
Where does Dr. Michael Anthony Ciliberto practice?
Dr. Ciliberto practices at 200 Hawkins Drive, Iowa City, IA 52242. Dr. Ciliberto's primary practice is University of Iowa Health Care Medical Center in Iowa City, Iowa, part of The University of Iowa.
What is Dr. Michael Anthony Ciliberto's office phone number?
The practice phone on file for Dr. Ciliberto is (319) 356-1616.
What is Dr. Michael Anthony Ciliberto's medical license number?
Dr. Ciliberto holds Iowa license MD-41060, one of the licenses on file in 2 states.
Which states has Dr. Michael Anthony Ciliberto been licensed in?
Dmand AI has state licenses on file for Dr. Ciliberto in Iowa and Missouri.
Which hospitals is Dr. Michael Anthony Ciliberto affiliated with?
Dr. Ciliberto practices at University of Iowa Health Care Medical Center in Iowa City, Iowa.
What medical group is Dr. Michael Anthony Ciliberto part of?
Dr. Ciliberto is linked to Scanlan Center for School Mental Health Clinic.
Does Dr. Michael Anthony Ciliberto accept Medicare?
Yes. CMS lists Dr. Ciliberto as accepting Medicare assignment.
What is Dr. Michael Anthony Ciliberto's MIPS score?
Dr. Ciliberto's MIPS final score for performance year 2024 is 80 out of 100, reported as part of a group.
Show 7 more questionsShow fewer questions
How many Medicare patients does Dr. Michael Anthony Ciliberto see?
CMS counts 12 Medicare patients who saw Dr. Ciliberto in 2024, with an average age of 30.
Where did Dr. Michael Anthony Ciliberto go to medical school?
Dr. Ciliberto graduated from Washington University School of Medicine in 2005.
What drugs does Dr. Michael Anthony Ciliberto prescribe most?
In 2024 Medicare Part D data, Dr. Ciliberto's most prescribed drugs by claims were Clobazam, Xcopri and Levetiracetam.
Has Dr. Michael Anthony Ciliberto received payments from drug or device companies?
CMS Open Payments shows $2,798 in general payments to Dr. Ciliberto from 5 companies from 2016 to 2024. The largest total came from Zogenix Inc.
How long has Dr. Michael Anthony Ciliberto been practicing?
Dr. Ciliberto graduated from medical school in 2005, 21 years ago.
Does Dr. Michael Anthony Ciliberto do research?
Dmand AI links 24 publications to Dr. Ciliberto, published from 2011 to 2025. Dr. Ciliberto has worked on 3 clinical trials.
Who does Dr. Michael Anthony Ciliberto publish with?
Dr. Ciliberto's most frequent co-authors are Lily C. Wong-Kisiel, MD (8 shared papers), Rani Kaur Singh, MD (6 shared papers) and Brian J. Dlouhy, MD (5 shared papers).
Selling to epilepsy practices?
See epilepsy physicians in Iowa by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card